有报道称私募股权有意收购后，Bausch & Lomb上涨

Bausch & Lomb (NYSE:BLCO) rose 1.8% in premarket trading after a report about private equity interest in a takeover of the eyecare company.

Private equity firms including Blackstone (BX), Advent International, TPG Capital (TPG), CVC Capital and Hellman & Friedman are evaluating possible offers for Bausch & Lomb (BLCO), according to a Financial Times report on Wednesday, which cited people familiar with the matter.  Bidders have a deadline of Friday to express interest in the company.

There's no guarantee that the sales process will result in a deal and Bausch Health (BHC) is also looking at other alternatives, including refinancing some of its debt.  A potential sale price for Bausch & Lomb (BLCO) wasn't known, but it will likely be at a premium to the current enterprise value, which includes debt, of $11.5 billion.

The FT story comes after the newspaper reported on Saturday that said Bausch + Lomb (BLCO) is exploring a sale to address concerns raised by lenders such as Apollo Global Management (APO) over its planned separation from its parent, Bausch Health (BHC). The Canadian eyecare firm is working with advisers from Goldman Sachs to evaluate buyers’ interest in the business, which was split from Bausch Health (BHC) in 2022.